Dr. Hochster on Take-Home Message of the POLO Trial in Pancreatic Cancer

Howard S. Hochster, MD, FACP, associate director for clinical research and director, Gastrointestinal Oncology, Rutgers Cancer Institute of New Jersey, director of oncology research, RWJBarnabas Health, discusses important takeaways from the randomized, double-blind, phase III POLO trial in pancreatic cancer.